BIOMEDICAL SYSTEMS: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
BIOMEDICAL SYSTEMS
Largest movements
- Receivables within one year +€1.0m
up €1.0m (+10.6%), from €9.7m to €10.7m
of which Other amounts receivable: +€991,984
- Cash -€450,329
down €450,329 (-49.0%), from €918,132 to €467,803
mainly Receivables within one year (-€1.0m) and Other debts (-€191,318)
- Profit (loss) carried forward +€594,055
up €594,055 (+7.1%), from €8.4m to €9.0m
- Tax, wage and social debts +€283,685
up €283,685 (+65.6%), from €432,742 to €716,427
of which Taxes: +€289,237
- Other debts -€191,318
down €191,318 (-13.5%), from €1.4m to €1.2m
- Advances received -€149,453
no longer reported in 2025 (was €149,453)
- Staff costs -€725,806
down €725,806 (-21.7%), from €3.3m to €2.6m
- Gross operating margin -€257,474
down €257,474 (-6.6%), from €3.9m to €3.7m
- Other operating charges +€188,974
up €188,974 (+4980.4%), from €3,794 to €192,768
- Financial charges +€41,573
up €41,573 (+194.6%), from €21,361 to €62,935
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €10,603,352 | €11,232,621 | +€629,270 | +5.9% |
| Fixed assets | 21/28 | €16,804 | - | -€16,804 | |
| Tangible fixed assets | 22/27 | €2,230 | - | -€2,230 | |
| Furniture and vehicles | 24 | €2,230 | - | -€2,230 | |
| Financial fixed assets | 28 | €14,574 | - | -€14,574 | |
| Current assets | 29/58 | €10,586,547 | €11,232,621 | +€646,074 | +6.1% |
| Amounts receivable within one year | 40/41 | €9,658,528 | €10,684,204 | +€1.0m | +10.6% |
| Trade receivables | 40 | €173 | €33,866 | +€33,692 | +19425.9% |
| Other amounts receivable | 41 | €9,658,354 | €10,650,338 | +€991,984 | +10.3% |
| Cash at bank and in hand | 54/58 | €918,132 | €467,803 | -€450,329 | -49.0% |
| Deferred charges and accrued income | 490/1 | €9,888 | €80,614 | +€70,726 | +715.3% |
| Total equity and liabilities | 10/49 | €10,603,352 | €11,232,621 | +€629,270 | +5.9% |
| Equity | 10/15 | €8,460,986 | €9,055,041 | +€594,055 | +7.0% |
| Contributions | 10/11 | €67,000 | €67,000 | = | 0.0% |
| Reserves | 13 | €6,700 | €6,700 | = | 0.0% |
| Non-distributable reserves | 130/1 | €6,700 | €6,700 | = | 0.0% |
| Other | 1319 | €6,700 | €6,700 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,387,286 | €8,981,341 | +€594,055 | +7.1% |
| Amounts payable | 17/49 | €2,142,365 | €2,177,580 | +€35,215 | +1.6% |
| Amounts payable within one year | 42/48 | €2,142,365 | €2,177,580 | +€35,215 | +1.6% |
| Trade debts | 44 | €144,512 | €236,813 | +€92,300 | +63.9% |
| Suppliers | 440/4 | €144,512 | €236,813 | +€92,300 | +63.9% |
| Advances received on contracts in progress | 46 | €149,453 | - | -€149,453 | |
| Taxes, remuneration and social security | 45 | €432,742 | €716,427 | +€283,685 | +65.6% |
| Taxes | 450/3 | €9,685 | €298,922 | +€289,237 | +2986.6% |
| Remuneration and social security | 454/9 | €423,057 | €417,506 | -€5,552 | -1.3% |
| Other amounts payable | 47/48 | €1,415,658 | €1,224,340 | -€191,318 | -13.5% |
| Non-recurring operating income | 76A | €3,620 | - | -€3,620 | |
| Remuneration, social security and pensions | 62 | €3,347,311 | €2,621,505 | -€725,806 | -21.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €8,953 | €2,231 | -€6,722 | -75.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €9,896 | €3,944 | -€5,951 | -60.1% |
| Other operating charges | 640/8 | €3,794 | €192,768 | +€188,974 | +4980.4% |
| Gross operating margin | 9900 | €3,927,470 | €3,669,996 | -€257,474 | -6.6% |
| Operating profit (loss) | 9901 | €557,516 | €849,548 | +€292,031 | +52.4% |
| Financial income | 75/76B | €41,873 | €9,630 | -€32,243 | -77.0% |
| Recurring financial income | 75 | €41,873 | €9,630 | -€32,243 | -77.0% |
| Financial charges | 65/66B | €21,361 | €62,935 | +€41,573 | +194.6% |
| Recurring financial charges | 65 | €21,361 | €62,935 | +€41,573 | +194.6% |
| Profit (loss) for the period before taxes | 9903 | €578,028 | €796,243 | +€218,215 | +37.8% |
| Income taxes | 67/77 | €203,439 | €202,188 | -€1,251 | -0.6% |
| Profit (loss) for the period | 9904 | €374,589 | €594,055 | +€219,466 | +58.6% |
| Profit (loss) for the period to be appropriated | 9905 | €374,589 | €594,055 | +€219,466 | +58.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.